• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病患者脑脊液α-突触核蛋白聚集的影像学标志物。

Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients.

作者信息

Droby Amgad, Yoffe-Vasiliev Avital, Atias Daniel, Fraser Kyle B, Mabrouk Omar S, Omer Nurit, Bar-Shira Anat, Gana-Weisz Mali, Goldstein Orly, Artzi Moran, Ben Bashat Dafna, Alcalay Roy N, Orr-Urtreger Avi, Shirvan Julia C, Cedarbaum Jesse M, Giladi Nir, Mirelman Anat, Thaler Avner

机构信息

Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.

Laboratory for Early Markers of Neurodegeneration, Neurological Institute, Tel Aviv Medical Center, Tel Aviv, Israel.

出版信息

NPJ Parkinsons Dis. 2025 Jan 3;11(1):7. doi: 10.1038/s41531-024-00854-4.

DOI:10.1038/s41531-024-00854-4
PMID:39753572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11698941/
Abstract

Alpha-synuclein (αS) aggregation is a widely regarded hallmark of Parkinson's disease (PD) and can be detected through synuclein amplification assays (SAA). This study investigated the association between cerebrospinal fluid (CSF) radiological measures in 41 PD patients (14 iPD, 14 GBA1-PD, 13 LRRK2-PD) and 14 age-and-sex-matched healthy controls. Quantitative measures including striatal binding ratios (SBR), whole-brain and deep gray matter volumes, neuromelanin-MRI (NM-MRI), functional connectivity (FC), and white matter (WM) diffusion-tensor imaging (DTI) were calculated. Nine LRRK2-PD patients were SAA-negative (PD-SAA-). PD-SAA+ patients showed lower whole-brain gray matter, putamenal, brainstem, and substantia nigra volumes, reduced FC in the left caudate, and lower fractional anisotropy in the left fronto-occipital fasciculus compared to PD-SAA-. Taken together, αS aggregation was observed in iPD, GBA1-PD, and 38% of LRRK2-PD patients, and this was associated with reduced regional brain volumes, altered caudal FC, and SBRs. These changes were less pronounced in PD-SAA-, possibly suggesting a milder neurodegenerative process.

摘要

α-突触核蛋白(αS)聚集是帕金森病(PD)广泛认可的一个标志,可通过突触核蛋白扩增检测(SAA)来检测。本研究调查了41例PD患者(14例散发性帕金森病患者(iPD)、14例GBA1基因相关帕金森病患者(GBA1-PD)、13例富亮氨酸重复激酶2基因相关帕金森病患者(LRRK2-PD))与14名年龄和性别匹配的健康对照者脑脊液(CSF)的影像学指标之间的关联。计算了包括纹状体结合率(SBR)、全脑和深部灰质体积、神经黑色素磁共振成像(NM-MRI)、功能连接(FC)以及白质(WM)扩散张量成像(DTI)等定量指标。9例LRRK2-PD患者SAA检测为阴性(PD-SAA-)。与PD-SAA-患者相比,PD-SAA+患者的全脑灰质、壳核、脑干和黑质体积更小,左侧尾状核的FC降低,左侧额枕束的分数各向异性更低。总体而言,在iPD、GBA1-PD以及38%的LRRK2-PD患者中观察到了αS聚集,这与脑区体积减小、尾侧FC改变以及SBR有关。这些变化在PD-SAA-患者中不太明显,这可能表明神经退行性变过程较为轻微。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c7/11698941/36142f1ed24f/41531_2024_854_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c7/11698941/bd1ef69c7ca9/41531_2024_854_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c7/11698941/19bc0c37d673/41531_2024_854_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c7/11698941/36142f1ed24f/41531_2024_854_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c7/11698941/bd1ef69c7ca9/41531_2024_854_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c7/11698941/19bc0c37d673/41531_2024_854_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/02c7/11698941/36142f1ed24f/41531_2024_854_Fig3_HTML.jpg

相似文献

1
Radiological markers of CSF α-synuclein aggregation in Parkinson's disease patients.帕金森病患者脑脊液α-突触核蛋白聚集的影像学标志物。
NPJ Parkinsons Dis. 2025 Jan 3;11(1):7. doi: 10.1038/s41531-024-00854-4.
2
Progressive Decline in Gray and White Matter Integrity in Parkinson's Disease: An Analysis of Longitudinal Parkinson Progression Markers Initiative Diffusion Tensor Imaging Data.帕金森病中灰质和白质完整性的渐进性下降:帕金森病纵向进展标志物计划扩散张量成像数据分析
Front Aging Neurosci. 2018 Oct 8;10:318. doi: 10.3389/fnagi.2018.00318. eCollection 2018.
3
Association between the Amplification Parameters of the α-Synuclein Seed Amplification Assay and Clinical and Genetic Subtypes of Parkinson's Disease.α-突触核蛋白种子扩增试验的扩增参数与帕金森病临床及基因亚型之间的关联
Mov Disord. 2025 Feb;40(2):305-314. doi: 10.1002/mds.30085. Epub 2024 Dec 18.
4
Longitudinal striatal dopamine transporter binding and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in Parkinson's disease.帕金森病患者纹状体多巴胺转运体纵向结合与脑脊液α-突触核蛋白、淀粉样β、总tau 和磷酸化 tau。
Neurol Sci. 2023 Feb;44(2):573-585. doi: 10.1007/s10072-022-06440-x. Epub 2022 Oct 13.
5
Accurate Detection of α-Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort.从孤立性快速眼动睡眠行为障碍和帕金森病患者的脑脊液中准确检测 α-突触核蛋白种子在 DeNovo 帕金森(DeNoPa)队列中的研究。
Mov Disord. 2023 Apr;38(4):567-578. doi: 10.1002/mds.29329. Epub 2023 Feb 13.
6
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.采用 α-突触核蛋白种子扩增评估帕金森进展标志物倡议队列参与者的异质性:一项横断面研究。
Lancet Neurol. 2023 May;22(5):407-417. doi: 10.1016/S1474-4422(23)00109-6.
7
Atrophy-related corticospinal changes in advanced Parkinson's disease are associated with the genetic etiology of the disease.晚期帕金森病中与萎缩相关的皮质脊髓改变与该疾病的遗传病因有关。
J Parkinsons Dis. 2024 Nov;14(8):1584-1593. doi: 10.3233/JPD-240267. Epub 2024 Nov 4.
8
Diffusion basis spectrum imaging detects pathological alterations in substantia nigra and white matter tracts with early-stage Parkinson's disease.扩散张量谱成像检测早期帕金森病患者黑质和白质束的病理改变。
Eur Radiol. 2023 Dec;33(12):9109-9119. doi: 10.1007/s00330-023-09780-0. Epub 2023 Jul 12.
9
Progression of Regional Microstructural Degeneration in Parkinson's Disease: A Multicenter Diffusion Tensor Imaging Study.帕金森病区域微观结构退变的进展:一项多中心扩散张量成像研究
PLoS One. 2016 Oct 31;11(10):e0165540. doi: 10.1371/journal.pone.0165540. eCollection 2016.
10
Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease.帕金森病患者脑白质和深部灰质的平均弥散度改变。
Neurosci Lett. 2013 Aug 29;550:64-8. doi: 10.1016/j.neulet.2013.06.050. Epub 2013 Jul 3.

引用本文的文献

1
Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohort.PPMI队列中散发性和遗传性帕金森病的基线α-突触核蛋白播种活性与疾病进展
EBioMedicine. 2025 Aug 6;119:105866. doi: 10.1016/j.ebiom.2025.105866.
2
Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohort.PPMI队列中散发性和遗传性帕金森病的基线α-突触核蛋白播种活性与疾病进展
medRxiv. 2025 Apr 2:2024.09.27.24311107. doi: 10.1101/2024.09.27.24311107.
3
Carriers of pathogenic variants show a milder, anatomically distinct brain signature of Parkinson's disease.

本文引用的文献

1
Prevalence of Concomitant Pathologies in Parkinson's Disease: Implications for Prognosis, Diagnosis, and Insights into Common Pathogenic Mechanisms.帕金森病合并症的患病率:对预后、诊断的影响及对常见致病机制的见解
J Parkinsons Dis. 2024;14(1):35-52. doi: 10.3233/JPD-230154.
2
Incidence and morphology of secondary TDP-43 proteinopathies: Part 1.继发性 TDP-43 蛋白病的发病率和形态学:第 1 部分。
Folia Neuropathol. 2022;60(3):267-276. doi: 10.5114/fn.2022.120314.
3
Neuromelanin and T*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson's disease.
携带致病变体的个体表现出一种较为轻微、在解剖学上有明显差异的帕金森病脑部特征。
medRxiv. 2025 Mar 10:2025.03.09.25323610. doi: 10.1101/2025.03.09.25323610.
神经黑色素与T*磁共振成像用于评估遗传易患、前驱期及有症状的帕金森病。
NPJ Parkinsons Dis. 2022 Oct 21;8(1):139. doi: 10.1038/s41531-022-00405-9.
4
Regional changes of brain structure during progression of idiopathic Parkinson's disease - A longitudinal study using deformation based morphometry.特发性帕金森病进展过程中脑结构的区域性变化 - 使用基于变形的形态测量学的纵向研究。
Cortex. 2022 Jun;151:188-210. doi: 10.1016/j.cortex.2022.03.009. Epub 2022 Mar 28.
5
Genetics of cognitive dysfunction in Parkinson's disease.帕金森病认知功能障碍的遗传学
Prog Brain Res. 2022;269(1):195-226. doi: 10.1016/bs.pbr.2022.01.015. Epub 2022 Feb 4.
6
Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers.LRRK2和GBA突变携带者中异常的多巴胺转运体与功能连接模式。
NPJ Parkinsons Dis. 2022 Mar 3;8(1):20. doi: 10.1038/s41531-022-00285-z.
7
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease.独立的α-突触核蛋白种子扩增检测方法对早期帕金森病的高诊断性能。
Acta Neuropathol Commun. 2021 Nov 6;9(1):179. doi: 10.1186/s40478-021-01282-8.
8
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies.脑脊液 α-突触核蛋白种籽活性与帕金森病和路易体痴呆遗传状态的关联。
Acta Neuropathol Commun. 2021 Oct 30;9(1):175. doi: 10.1186/s40478-021-01276-6.
9
Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression.用于诊断早期帕金森病并预测多巴胺能缺陷进展的种子扩增检测法。
Mov Disord. 2021 Oct;36(10):2444-2446. doi: 10.1002/mds.28715. Epub 2021 Jul 8.
10
Diffusion Tensor Imaging in Parkinson's Disease and Parkinsonian Syndrome: A Systematic Review.帕金森病和帕金森综合征中的扩散张量成像:一项系统综述。
Front Neurol. 2020 Sep 25;11:531993. doi: 10.3389/fneur.2020.531993. eCollection 2020.